STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 90 filers reported holding STOKE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $2,879,000 | -5.7% | 120,000 | 0.0% | 0.08% | +6.6% |
| Q3 2021 | $3,053,000 | -24.4% | 120,000 | 0.0% | 0.08% | -26.2% |
| Q2 2021 | $4,039,000 | -13.3% | 120,000 | 0.0% | 0.10% | -25.9% |
| Q1 2021 | $4,661,000 | -37.3% | 120,000 | 0.0% | 0.14% | -36.8% |
| Q4 2020 | $7,432,000 | +84.9% | 120,000 | 0.0% | 0.22% | +22.2% |
| Q3 2020 | $4,019,000 | +40.5% | 120,000 | 0.0% | 0.18% | +6.5% |
| Q2 2020 | $2,860,000 | +4.1% | 120,000 | 0.0% | 0.17% | -42.1% |
| Q1 2020 | $2,748,000 | -25.4% | 120,000 | -7.7% | 0.29% | -13.9% |
| Q4 2019 | $3,682,000 | -99.9% | 130,000 | 0.0% | 0.34% | +17.3% |
| Q3 2019 | $2,793,700,000 | +12.7% | 130,000 | +52.9% | 0.29% | +24.6% |
| Q2 2019 | $2,479,450,000 | – | 85,000 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 17,161,713 | $666,561,000 | 74.20% |
| RTW INVESTMENTS, LP | 3,644,248 | $141,543,000 | 2.21% |
| Redmile Group, LLC | 2,544,062 | $98,811,000 | 1.39% |
| Cormorant Asset Management, LP | 1,437,807 | $55,844,000 | 1.24% |
| ACUTA CAPITAL PARTNERS, LLC | 45,000 | $1,748,000 | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 150,729 | $5,854,000 | 0.45% |
| HighVista Strategies LLC | 13,692 | $532,000 | 0.40% |
| Birchview Capital, LP | 15,000 | $583,000 | 0.35% |
| Perceptive Advisors | 671,978 | $26,100,000 | 0.33% |
| GILDER GAGNON HOWE & CO LLC | 1,265,950 | $49,169,000 | 0.26% |